Company Search:
Advanced Search
Sponsored Links
Xiangxue Pharmaceutical Co Ltd Company Snapshot
Xiangxue Pharmaceutical Co Ltd operates within the Pharmaceutical preparations sector. In addition to historical fundamental analyses, the complete report available to purchase compares Xiangxue Pharmaceutical Co Ltd with three other companies in this sector in China: Guangdong Zhongsheng Pharmaceutical Co Ltd (2016 sales of 1.69 billion Chinese Renmimbi [US$263.03 million] of which 93% was Medicine Manufacture), SSY Group Ltd (2.02 billion Chinese Renmimbi [US$314.59 million] of which 94% was Intravenous Infusion Solution and Others), and Anhui Fengyuan Pharmaceutical (2.03 billion Chinese Renmimbi [US$316.04 million] of which 63% was Medicine Retail Circulation).

Sales Analysis. During the year ended December of 2016, sales at Xiangxue Pharmaceutical Co Ltd were 1.86 billion Chinese Renmimbi (US$289.25 million). This is an increase of 27.2% versus 2015, when the company's sales were 1.46 billion Chinese Renmimbi. Sales of Other Operations saw an increase that was more than double the company's growth rate: sales were up 748.5% in 2016, from 14.01 million Chinese Renmimbi to 118.83 million Chinese Renmimbi. Xiangxue Pharmaceutical Co Ltd also saw significant increases in sales in Chinese Herbal Medicines (up 57.9% to 623.94 million Chinese Renmimbi) and Pharmaceutical Distribution (up 226.8% to 518.45 million Chinese Renmimbi) . Not all segments of Xiangxue Pharmaceutical Co Ltd experienced an increase in sales in 2016: sales of Medical Apparatus and Instruments fell 42.6% to 20.98 million Chinese Renmimbi. (However, this segment's sales were only a very small portion of the company's overall sales). Xiangxue Pharmaceutical Co Ltd also experienced decreases in sales in Pharmaceutical Manufacturing (down 27.4% to 563.22 million Chinese Renmimbi) .
Company ReportsSubscriptions
Looking For More?
Purchace an In-Depth Report
Xiangxue Pharmaceutical Co Ltd
  Stock Performance Chart for Xiangxue Pharmaceutical Co Ltd
  Stock Data: Recent Stock Performance:
  Current Price (1/19/2018): 9.14
(Figures in Chinese Renmimbi)
1 Week 2.2%   13 Weeks 5.4%  
4 Weeks -9.0%   52 Weeks -23.1%  
Xiangxue Pharmaceutical Co Ltd Key Data:
  Ticker: 300147 Country: China
  Exchanges: SZN Major Industry: Pharmaceuticals & Biotechnology
    Sub Industry: Pharmaceutical Preparations
  2016 Sales 1,861,055,973
(Year Ending Jan 2017).
Employees: 3,616
  Currency: Chinese Renmimbi Market Cap: 6,045,893,702
  Fiscal Yr Ends: December Shares Outstanding: 661,476,335
  Share Type: A Gu Closely Held Shares:
Sponsored Links
Feedback | Terms and Conditions | Privacy Policy | Site Index
CorporateInformation® website and selected data Copyright © 2000 - by The Winthrop Corporation. All Rights Reserved. Except for quotations by established news media, no pages on this site may be reproduced, stored in a retrieval system, or transmitted for commercial purposes, in any form or by any means, electronic, mechanical, photocopying, recording, or otherwise without prior written permission. Information is believed reliable, but accuracy, completeness and opinions are not guaranteed.